Reference
[1]Boden, Guenther, Sargrad, Karin, Homko, Carol, Mozzoli, Maria, & Stein, T. Peter. (2005). Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes. Annals of Internal Medicine, 142(6), 403-411.
[2]Hussain, T. A., Mathew, T. C., Dashti, A. A., Asfar, S., Al-Zaid, N., & Dashti, H. M. (2012). Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition, 28(10), 1016-21.
[3]Morag, N. K., Eran, C., & Gold, B. (2002). High blood triglycerides are independent risk factors for stroke. Circulation, 26, 6-7.
[4]Westman, E. C., Yancy, W. S., Jr, Mavropoulos, J. C., Marquart, M., & McDuffie, J. R. (2008). The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutrition & metabolism, 5, 36. https://doi.org/10.1186/1743-7075-5-36
[5]Kristjansson, K., Lissner, L., Bengtsson, C., Lapidus, L., & Blohmé, G. (1993). The Interrelationships between Fasting Serum Insulin Level, Obesity and Blood Pressure in Women: Results from across-Sectional Population Study of Women in Gothenburg, Sweden. Hypertension Research, 16(3), 197-201.
[6]Dunaif, A. (1997). Insulin resistance and the polycystic ovary syndrome : Mechanism and implications for pathogenesis. Endocrine Reviews,18(6), 774-800.
[7]Yau, Tiffany T. L, Ng, Noel Y. H, Cheung, L.P, & Ma, Ronald C. W. (2017). Polycystic ovary syndrome: A common reproductive syndrome with long-term metabolic consequences. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi,23(6), 622-634.
[8]Moran, L. J, Noakes, M, Clifton, P. M, Tomlinson, L, & Norman, R. J. (2003). Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 88(2), 812-819.
[9]Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G, & Kofler, B.. (2020). Ketogenic diet in the treatment of cancer – Where do we stand? Molecular Metabolism (Germany), 33, 102-121.
[10]Weber, D. D., Aminazdeh-Gohari, S., & Kofler, B. (2018). Ketogenic diet in cancer therapy. Aging, 10(2), 164–165. https://doi.org/10.18632/aging.101382
[11]Shanmugalingam, T., Bosco, C., Ridley, A. J., & Van Hemelrijck, M. (2016). Is there a role for IGF-1 in the development of second primary cancers?. Cancer medicine, 5(11), 3353–3367. https://doi.org/10.1002/cam4.871
[12]Youm, Y. H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., Kang, S., Horvath, T. L., Fahmy, T. M., Crawford, P. A., Biragyn, A., Alnemri, E., & Dixit, V. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature medicine, 21(3), 263–269.
[13]Youm, Y. H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., Kang, S., Horvath, T. L., Fahmy, T. M., Crawford, P. A., Biragyn, A., Alnemri, E., & Dixit, V. D. (2015). The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature medicine, 21(3), 263–269.
[14]James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., ... & Briggs, A. M. (2018). Global, regional, and national incidence, prevalence, and years lived with
[15]Włodarczyk, A., & Cubała, W. J. (2019). Mechanisms of action of the ketogenic diet in depression. Neuroscience and biobehavioral reviews, 107, 422-423.